Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
Iannone added that results for the ongoing Phase II Parkinson's disease tremor trial (NCT05642442) are expected in the first quarter of 2025. The candidate remained well tolerated ...
Clinical Trials Arena
5 days ago